UnknownPhase 2

CDP-choline Treatment in ATS Users

South Korea160 participantsStarted 2015-03

Plain-language summary

This study is a 12-week, randomized, double-blind, placebo-controlled trial of cytidine-5'-diphosphate choline in amphetamine-type stimulants-using adolescents.

Who can participate

Age range14 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 14-40 years * Amphetamine (or amphetamine-like) use disorder (DSM-IV-TR) * Informed consent * Seeking treatment Exclusion Criteria: * Major medical or neurological illnesses * Psychiatric illnesses requiring hospitalization, prescription of psychotropic medications, or emergency psychiatric interventions * Current and past diagnosis of a psychotic disorder, bipolar disorder, conduct disorder, or attention-deficit hyperactivity disorder * Occasional ATS use (less than monthly use) * IQ of 80 or lower * Pregnancy or breastfeeding * Clinically significant suicidal or homicidal ideation * Substance use disorders (substances other than amphetamine or MA)

What they're measuring

the total number of amphetamine- and methamphetamine(MA)-negative samples using urine screening

Timeframe: baseline through 12 weeks

abstinence which is defined as five or more consecutive weeks of amphetamine- and MA-negative samples

Timeframe: baseline through 12 weeks

treatment program retention

Timeframe: baseline through 12 weeks

Trial details

NCT IDNCT02630069

SponsorEwha Womans University Mokdong Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12

Contact for this trial

Sujung Yoon, MD, PhD

82-2-3277-2478 sujungjyoon@ewha.ac.kr

View on ClinicalTrials.gov More Substance Use Disorders trials